Bromantane

• CAT Number: R054764
• CAS Number: 87913-26-6
• Molecular Formula: C16H20BrN
• Molecular Weight: 306.247
• Purity: 98%
• Storage: -20°C
• IUPAC Name: N-(4-bromophenyl)adamantan-2-amine
• InChI: InChI=1S/C16H20BrN/c17-14-1-3-15(4-2-14)18-16-12-6-10-5-11(8-12)9-13(16)7-10/h1-4,10-13,16,18H,5-9H2
• InChIKey: LWJALJDRFBXHKX-UHFFFAOYSA-N
• SMILES: C1C2CC3CC1CC(C2)C3NC4=CC=C(C=C4)Br

Bromantane (Cat. No: R054764) is a stimulant. It acts on the central nervous system, can stimulate the release of dopamine, and is a sports-banned stimulant drug. Bromantane is currently mainly used in adjuvant therapy for Parkinson’s disease, mood disorders, and other psychiatric diseases. This product is for scientific research only.

Reference

1. Eksp Klin Farmakol. 1995 Jul-Aug;58(4):8-11.

[The effect of bromantane on the dopamin- and serotoninergic systems of the rat
brain].

[Article in Russian]

Kudrin VS, Sergeeva SA, Krasnykh LM, Miroshnichenko II, Grekhova TV, Gaĭnetdinov
RR.

The effect of acute and chronic administration (50 mg/kg, p.o.) of a new
immunostimulator, bromantan exhibiting psychostimulant features on the content of
NE, DA and 5-HT, and their metabolites are studied. Bromantan induced a
significant increase in the 5-HT and 5-HIAA content in the frontal cortex and
delayed an increase in their content in subcortical brain regions. A stable
decrease in the 5-HT and 5-HIAA levels in the cerebellum is observed. The drug
also affected the DA parameters of the brain thus suggesting an important role of
dopaminergic system in the mechanism of pharmacological effects of the drug.